281 related articles for article (PubMed ID: 9527904)
1. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
2. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
3. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
Tanaka M; Tanaka K
Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
[TBL] [Abstract][Full Text] [Related]
4. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
[TBL] [Abstract][Full Text] [Related]
6. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
8. [A study on pathomechanisms of paraneoplastic neurological syndrome].
Tanaka K
Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823
[TBL] [Abstract][Full Text] [Related]
9. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
Tanaka M; Tanaka K; Tsuji S
Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
[No Abstract] [Full Text] [Related]
11. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration.
Tanaka M; Tanaka K; Tsuji S; Kawata A; Kojima S; Kurokawa T; Kira J; Takiguchi M
J Neurol Sci; 2001 Jul; 188(1-2):61-5. PubMed ID: 11489286
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific killer cells in paraneoplastic cerebellar degeneration.
Albert ML; Darnell JC; Bender A; Francisco LM; Bhardwaj N; Darnell RB
Nat Med; 1998 Nov; 4(11):1321-4. PubMed ID: 9809559
[TBL] [Abstract][Full Text] [Related]
14. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Nakajima T; Yamazaki M; Miyatake T; Tsuji S
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):256-7. PubMed ID: 7876871
[No Abstract] [Full Text] [Related]
15. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.
Storstein A; Monstad SE; Honnorat J; Vedeler CA
J Neuroimmunol; 2004 Oct; 155(1-2):150-4. PubMed ID: 15342206
[TBL] [Abstract][Full Text] [Related]
17. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
Cohen AB; Zupa-Fernandez A; Dalmau J; Galetta SL
J Neurol Sci; 2004 Oct; 225(1-2):153-5. PubMed ID: 15465100
[TBL] [Abstract][Full Text] [Related]
18. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
19. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
20. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
Grisold W; Drlicek M; Liszka U
Nervenarzt; 1991 Oct; 62(10):609-14. PubMed ID: 1749452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
